Search results
Insider Sell: Amicus Therapeutics Inc President and CEO Bradley Campbell Sells 11,700 Shares
GuruFocus.com via Yahoo Finance· 7 months agoOn November 1, 2023, Bradley Campbell, President and CEO of Amicus Therapeutics Inc (NASDAQ:FOLD),...
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 months agoAmicus Therapeutics, Inc. (NASDAQ:FOLD) Q4 2023 Earnings Call Transcript February 28, 2024 Amicus...
Amicus Therapeutics Inc (FOLD) Reports 21% Revenue Growth in 2023, Eyes Non-GAAP Profitability ...
GuruFocus.com via Yahoo Finance· 3 months agoTotal Revenue: $399.4 million in 2023, marking a 21% increase year-over-year. Galafold Revenue: Grew by 18% to $387.8 million, with projections of 11-16% growth in 2024. Net Loss: Reduced to ...
Amicus Therapeutics Inc (FOLD) Q1 2024 Earnings: Surpasses Revenue Estimates and Projects ...
GuruFocus.com via Yahoo Finance· 4 weeks agoRevenue: Reported $110.4M for Q1 2024, marking a 28% increase year-over-year, but fell short of the estimated $124.94M. Net Product Revenues: Achieved $110.4M, up 28% from $86.3M in the previous ...
Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More:...
Benzinga via Yahoo Finance· 2 years agoEditor's note: This story has been corrected to reflect that the FDA deferred action on Amicus...